Rebekah Clifford, MD
Dermatology · Murray, UTNPI 1053511584
Payments from drug & device makers
Across 110 payments — averaging $12.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arcutis Biotherapeutics, Inc.$553
- AbbVie$123
- Novartis$106
- Galderma Laboratories, L.p.$83
- LEO Pharma Inc.$67
- Johnson & Johnson$61
- plus $416 from 17 others
What the payments were for
- Food & beverage$1,410100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 64 | $553 |
| AbbVie | 7 | $123 |
| Novartis | 5 | $106 |
| Galderma Laboratories, L.p. | 4 | $83 |
| LEO Pharma Inc. | 3 | $67 |
| Johnson & Johnson | 3 | $61 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $59 |
| Therapeuticsmd, Inc. | 3 | $50 |
| Lilly USA, LLC | 2 | $43 |
| Pfizer | 2 | $30 |
| UCB, Inc. | 2 | $30 |
| Sanofi-aventis U.S. LLC | 2 | $30 |
| Biocompatibles, Inc. | 1 | $21 |
| Ascend Therapeutics US, LLC | 1 | $19 |
| Merck | 1 | $18 |
| Innocoll Pharmaceuticals Limited | 1 | $17 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $16 |
| Daiichi Sankyo Inc. | 1 | $16 |
| Avion Pharmaceuticals | 1 | $14 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
| BD | 1 | $13 |
| Organon | 1 | $13 |
| Boston Scientific | 1 | $13 |
How this compares
$1,410 in reported general payments places this provider in the 50th percentile of 163 dermatology providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 223 | $6,847 |
| Pimecrolimus | 18 | $3,162 |
| Triamcinolone Acetonide | 159 | $1,985 |
| Fluorouracil | 21 | $1,825 |
| Doxycycline Monohydrate | 60 | $1,508 |
| Mycophenolate Mofetil | 13 | $1,121 |
| Ketoconazole | 60 | $850 |
| Metronidazole | 23 | $783 |
| Tacrolimus | 15 | $722 |
| Finasteride | 37 | $540 |
| Doxepin Hcl | 18 | $261 |
| Terbinafine Hcl | 15 | $215 |
| Mupirocin | 16 | $161 |
| Prednisone | 17 | $94 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Murray
- Jamie RhoadsMurray$2.5M
- Sancy LeachmanMurray$34K
- Doug Lass ForshaWest Jordan$2.2M
- Michael PetersonSpanish Fork$1.6M
- Kristina DuffinSalt Lake City$1.2M
- Gerald KruegerSalt Lake City$1.1M
- Brian WilliamsMidvale$876K
- Jason HadleyBountiful$477K
- Mark TaylorSalt Lake City$473K
- Travis JamesProvidence$472K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.